Clinical Data (CLDA)

[surf1944]

7:22AM Clinical Data reports 3Q10 loss per share of ($0.63) vs. ($0.65) First Call consensus; revenue increased 12.5% y/y to $3.1 mln vs. $3.6 mln consensus (CLDA) 14.79 : Cash and cash equivalents at December 31, 2009, were $70.2 mln. This included net proceeds of $44.2 mln raised from a public offering of 2,750,000 shares of common stock at a price of $17.25 per share completed in November 2009.